Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Long- versus short-acting beta 2-agonists. Implications for drug therapy.

Literature DB >> 7512898

Long- versus short-acting beta 2-agonists. Implications for drug therapy.

L P Boulet¹.

Abstract

Entities: Gene

Mesh：

Substances：

Year: 1994 PMID： 7512898 DOI： 10.2165/00003495-199447020-00001

Source DB: PubMed Journal: Drugs ISSN： 0012-6667 Impact factor: 9.546

× No keyword cloud information.

162 in total

1. Comparative efficacy of salbutamol, ipratropium, and cromoglycate in the prevention of bronchospasm induced by exercise and hyperosmolar challenges.

Authors: L P Boulet; H Turcotte; S Tennina
Journal: J Allergy Clin Immunol Date: 1989-05 Impact factor: 10.793

2. Increased bronchial hyperresponsiveness after inhaling salbutamol during 1 year is not caused by subsensitization to salbutamol.

Authors: C P van Schayck; S J Graafsma; M B Visch; E Dompeling; C van Weel; C L van Herwaarden
Journal: J Allergy Clin Immunol Date: 1990-11 Impact factor: 10.793

3. Fenoterol and fatal asthma.

Authors: C Poole; S F Lanes; A M Walker
Journal: Lancet Date: 1990-04-14 Impact factor: 79.321

Review 4. Effect of beta-agonists and anticholinergic drugs on bronchial reactivity.

Authors: A E Tattersfield
Journal: Am Rev Respir Dis Date: 1987-10

5. Regular versus symptomatic aerosol bronchodilator treatment of asthma.

Authors: G L Shepherd; M R Hetzel; T J Clark
Journal: Br J Dis Chest Date: 1981-04

Review 6. Long-acting beta 2-adrenoceptor agonists: a new perspective in the treatment of asthma.

Authors: C G Löfdahl; K F Chung
Journal: Eur Respir J Date: 1991-02 Impact factor: 16.671

7. Bronchodilator and bronchoprotective effects of salmeterol in young patients with asthma.

Authors: F E Simons; N R Soni; W T Watson; A B Becker
Journal: J Allergy Clin Immunol Date: 1992-11 Impact factor: 10.793

8. Prolonged bronchodilating effect of formoterol versus procaterol in bronchial asthma.

Authors: A Chetta; M Del Donno; G Maiocchi; G Pisi; D Moretti; D Olivieri
Journal: Ann Allergy Date: 1993-02

9. Formoterol, a new inhaled beta-2 adrenergic agonist, has a longer blocking effect than albuterol on hyperventilation-induced bronchoconstriction.

Authors: J L Malo; A Cartier; C Trudeau; H Ghezzo; L Gontovnick
Journal: Am Rev Respir Dis Date: 1990-11

10. A comparison of oral procaterol and albuterol in reversible airflow obstruction.

Authors: T L Petty; M L Brandon; W W Busse; P Chervinsky; W Schoenweter; A Beaupre; L P Boulet; J Mazza
Journal: Am Rev Respir Dis Date: 1988-12

7 in total

Review 1. Regular treatment with long acting beta agonists versus daily regular treatment with short acting beta agonists in adults and children with stable asthma.

Authors: E H Walters; J A Walters; P W Gibson
Journal: Cochrane Database Syst Rev Date: 2002

2. National athletic trainers' association position statement: preventing sudden death in sports.

Authors: Douglas J Casa; Kevin M Guskiewicz; Scott A Anderson; Ronald W Courson; Jonathan F Heck; Carolyn C Jimenez; Brendon P McDermott; Michael G Miller; Rebecca L Stearns; Erik E Swartz; Katie M Walsh
Journal: J Athl Train Date: 2012 Jan-Feb Impact factor: 2.860